A Pilot Study of an Exercise-Based Patient Education Program in People with Multiple Sclerosis

Table 1

Overview of data of the 19 participants at the beginning (April 2010).

Prob. number	Gender ( = 1, = 2)	Age at study beginning	Diagnosis (year)	Actual clinical course	Medication	EDSS	Scripps	Sports/physiotherapy/occupational therapy
2	2	67	1994	Secondary progredient	No basic therapy	6.5	52	2x weekly
3	2	46	2001	Secondary progredient	Betaferone	6	48	2x weekly
4	1	34	2003	Relapse-remitting	Tysabri	3	79	None
5	2	56	1999	Primary progredient	Only homeopathy	5	61	Yes
6	2	41	2004	Relapse-remitting	Copaxone	3.5	74	1-2x weekly
7	2	56	1998	Relapse-remitting	Avonex	4.5	87	None
9	1	59	1996	Secondary progredient	No basic therapy	6.5	64+	2x weekly
10	2	44	2007	Relapse-remitting	Betaferone	3.5	73	Rehability sports
11	2	38	1997	Relapse-remitting	Copaxone	2	93	None
12	2	60	1983	Secondary progredient	None	6.5	74	Yes
13	2	46	2002	Secondary progredient	L-Thyroxine	3.5	84	Yes
14	1	58	1996	Secondary progredient	Interferone	6	78	Yes
15	1	43	2007	Primary progredient	No basic therapy	2	94	None
16	2	57	1995	Primary progredient	No basic therapy	4.5	73	2x weekly
17	2	49	1983	Relapse-remitting	Betaferone	6.5	67	2x weekly
18	2	45	2001	Secondary progredient	Copaxone	4	68	Yes
19	2	34	2004	Relapse-remitting	Only homeopathy	2	94	None
20	2	60	2008	Relapse-remitting	No basic therapy	3.5	74	Yes
21	2	49	1993	Secondary progredient	Mitoxantrone	4.5	57	2x weekly